No Data
No Data
Tianmushan Pharmaceutical Enterprise Gets Nod to Re-Register Baihe Gujin Oral Liquid
Express News | ST: Special treat: Lily Gold oral liquid re-registered and approved.
Express News | Special treat: received 17 pharmaceutical re-registration approval notices.
ST Muyao (600671.SH): The controlling subsidiary plans to lease property.
On September 9, Gelonhui announced that its holding subsidiary, Qingdao Simulation Medical Technology Co., Ltd., plans to lease the Yung Jia Life Science and Technology Industrial Park A# building located at 603 Jiushui East Road, Laoshan District, Qingdao City, from Yung Jia Run Industrial Co., Ltd. The premises will be used for production, research and development, and office purposes, with a leasing area of approximately 7,862.71 square meters, for a lease term of 3 years from September 7, 2024 to September 6, 2027; the rent is payable annually, with the first year's rent being 6.3138 million yuan, the second year's rent being 6.5146 million yuan, and the third year's rent being 6.7155 million yuan.
Hangzhou Tianmushan Pharmaceutical Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Hangzhou Tianmusan Pharmaceutical Co., Ltd.
No Data
No Data